NovoCare vs. LillyDirect: Manufacturer Cash-Pay Programs Compared
Prices verified May 22, 2026 · Updated for 2026
Both manufacturers now offer direct cash-pay programs that bypass traditional pharmacy pricing. NovoCare offers Wegovy injection at $349/mo and Wegovy pill at $149–$299/mo. LillyDirect offers Zepbound KwikPen at $299–$699/mo and Foundayo at $149/mo. For the cheapest brand-name entry, Foundayo and Wegovy pill both start at $149/mo. For maximum weight loss on brand-name, Zepbound through LillyDirect at $299/mo (lower doses) offers the best value-per-pound-lost.
The manufacturer direct-to-patient revolution
Until 2024, getting a brand-name GLP-1 without insurance meant paying list price ($1,000–$1,400/month) or navigating complex savings card programs. Both Novo Nordisk (NovoCare) and Eli Lilly (LillyDirect) now offer direct cash-pay programs that dramatically reduce costs—though they work differently and cover different medications.
Head-to-head comparison
| Feature | NovoCare (Novo Nordisk) | LillyDirect (Eli Lilly) |
|---|---|---|
| Medications | Wegovy (injection + pill), Ozempic, Rybelsus | Zepbound, Mounjaro, Foundayo |
| Weight loss drug pricing | Wegovy injection: $349/mo Wegovy pill: $149–$299/mo | Zepbound KwikPen: $299–$699/mo Foundayo: $149/mo |
| Cheapest entry point | $149/mo (Wegovy pill starter) | $149/mo (Foundayo) |
| Savings card (w/ insurance) | As low as $25/mo | As low as $25/mo |
| Savings card (no insurance) | Not eligible | $550/mo (Zepbound) |
| Oral option | ✅ Wegovy pill | ✅ Foundayo |
| Delivery | Mail-order pharmacy | Direct + Amazon Pharmacy option |
| Telehealth integration | Partners with various platforms | Amazon One Medical integration |
NovoCare: detailed breakdown
NovoCare is Novo Nordisk's patient services hub. For cash-pay patients without insurance coverage:
- Wegovy injection: $349/month at any dose level. No dose-based price escalation.
- Wegovy pill: $149/month for starter doses, $299/month for maintenance. The most affordable brand-name oral GLP-1 for weight loss.
- Savings card (commercial insurance): Patients with commercial insurance that covers Wegovy can pay as low as $25/month. Medicare, Medicaid, and government insurance are not eligible for savings cards (but the Medicare Bridge at $50/mo launches July 2026).
LillyDirect: detailed breakdown
LillyDirect is Eli Lilly's direct-to-patient platform, now integrated with Amazon Pharmacy for same-day delivery in eligible areas:
- Zepbound KwikPen: $299–$699/month depending on dose. The wide range reflects Zepbound's multiple dose levels (2.5mg through 15mg).
- Foundayo: $149/month flat. No dose-based pricing variation. The most convenient oral option (no fasting restrictions).
- Savings card (commercial insurance): As low as $25/month with qualifying coverage.
- Savings card (no insurance coverage): $550/month for Zepbound—better than list price but still significantly more than compounded alternatives.
Which program wins by scenario
| Scenario | Best choice | Monthly cost |
|---|---|---|
| Cheapest brand-name oral | Wegovy pill (NovoCare) or Foundayo (LillyDirect) | $149/mo |
| Maximum weight loss (brand) | Zepbound (LillyDirect) | $299–$699/mo |
| Best brand with insurance | Either — both offer $25/mo savings cards | $25/mo |
| No insurance, budget-conscious | Foundayo (LillyDirect) at $149 flat | $149/mo |
| Oral + no fasting restrictions | Foundayo (LillyDirect) | $149/mo |
| Proven CV benefits | Wegovy (NovoCare) | $349/mo injection |
The compounded alternative
Both NovoCare and LillyDirect are more expensive than compounded alternatives for most scenarios. Compounded semaglutide starts at $99/month (GobyMeds) and compounded tirzepatide at $133/month. The tradeoff: compounded is not FDA-approved and faces increasing regulatory pressure. For patients who want the certainty of brand-name with the convenience of oral, Foundayo at $149/month has nearly closed the price gap with compounded options.
🏥 Compare Brand-Name & Compounded Options
Compounded medications are not FDA-approved. Consult a licensed provider to determine if treatment is appropriate for you.
Sesame Care
Access to FDA-approved brand-name GLP-1 medications through licensed providers.
Get StartedEmbody
Compounded semaglutide with metabolic report, 1:1 guidance, and personalized plan.
Start for $149GobyMeds
LegitScript-verified. Semaglutide & tirzepatide bundles, free consult, free shipping.
Get StartedFound Health
Brand-name + compounded options with insurance coordination and structured coaching.
Get StartedSources & References
- NovoCare patient services: pricing verified May 2026.
- LillyDirect pricing: verified May 2026.
- Eli Lilly: Foundayo launch announcement, April 2026.
- Amazon Pharmacy: GLP-1 delivery availability, May 2026.